Literature DB >> 17018901

Unusual cyclin D1 positive marginal zone lymphoma of mediastinum.

Grzegorz Rymkiewicz1, Konrad Ptaszyński, Jan Walewski, Katarzyna Błachnio, Pawel Swoboda, Monika Gos, Ewa Paszkiewicz-Kozik, Renata Woroniecka, Barbara Pieńkowska-Grela, Małgorzata Czarnocka, Przemysław Janik.   

Abstract

We report a case of 43-yr-old Caucasian female with an unusual, cyclin D1 positive marginal zone lymphoma (MZL) of mucosa-associated lymphoid tissue (MALT) type of the mediastinum. To date, only about 30 cases of this entity have been published. They occur mainly in Asian females with a history of coexisting autoimmune disease. To our knowledge, this is the first case of mediastinal MZL with cyclin D1 expression. In the span of 6 yr this patient's tumor recurred three times, was surgically treated, and initially diagnosed as paraganglioma. The diagnosis was based on histopathological examination only. Our final diagnosis of MZL was made by combined evaluation of histopathology (HP), immunohistochemistry (IH), flow cytometry (FCM), fluorescence in situ hybridization (FISH), and molecular biology studies. We found a positive cyclin D1 reaction by IH and cyclin D1 mRNA (CCND1) overexpression by reverse transcription polymerase chain reaction (RT-PCR). Very high cyclin D1 to beta-actin mRNA ratio in this case was comparable with the ratio, characteristic for mantle cell lymphoma (MCL). However, there was no translocation t(11;14) found by FISH and an immunophenotype by IH and FCM was consistent with MZL ruling out MCL diagnosis. In addition, our case differs from other, previously reported thymic MZL lymphoma cases by no autoimmune disease association, Caucasian origin, and the absence of the plasmacytic differentiation on both HP/IH.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17018901     DOI: 10.1385/MO:23:3:423

Source DB:  PubMed          Journal:  Med Oncol        ISSN: 1357-0560            Impact factor:   3.738


  23 in total

1.  Expanded range of 11q13 breakpoints with differing patterns of cyclin D1 expression in B-cell malignancies.

Authors:  S D Raynaud; S Bekri; D Leroux; J Grosgeorge; B Klein; C Bastard; P Gaudray; M P Simon
Journal:  Genes Chromosomes Cancer       Date:  1993-10       Impact factor: 5.006

Review 2.  Recent advances in flow cytometry: application to the diagnosis of hematologic malignancy.

Authors:  C D Jennings; K A Foon
Journal:  Blood       Date:  1997-10-15       Impact factor: 22.113

Review 3.  Primary marginal zone lymphoma of the thymus.

Authors:  R B Lorsbach; G S Pinkus; A Shahsafaei; D M Dorfman
Journal:  Am J Clin Pathol       Date:  2000-06       Impact factor: 2.493

4.  Results of MIME salvage regimen for recurrent or refractory lymphoma.

Authors:  F Cabanillas; F B Hagemeister; P McLaughlin; W S Velasquez; S Riggs; L Fuller; T Smith
Journal:  J Clin Oncol       Date:  1987-03       Impact factor: 44.544

5.  Low-grade B-cell lymphoma of mucosa-associated lymphoid tissue arising in the thymus. A thymic lymphoma mimicking myoepithelial sialadenitis.

Authors:  P G Isaacson; J K Chan; C Tang; B J Addis
Journal:  Am J Surg Pathol       Date:  1990-04       Impact factor: 6.394

6.  Mediastinal lymphoma of clear cell type is a tumor corresponding to terminal steps of B cell differentiation.

Authors:  P Möller; G Moldenhauer; F Momburg; B Lämmler; M Eberlein-Gonska; S Kiesel; B Dörken
Journal:  Blood       Date:  1987-04       Impact factor: 22.113

7.  Differential expression of cyclin D1 in mantle cell lymphoma and other non-Hodgkin's lymphomas.

Authors:  N S Aguilera; K E Bijwaard; B Duncan; A E Krafft; W S Chu; S L Abbondanzo; J H Lichy; J K Taubenberger
Journal:  Am J Pathol       Date:  1998-12       Impact factor: 4.307

8.  Richter's syndrome: a report on 39 patients.

Authors:  L E Robertson; W Pugh; S O'Brien; H Kantarjian; C Hirsch-Ginsberg; A Cork; P McLaughlin; F Cabanillas; M J Keating
Journal:  J Clin Oncol       Date:  1993-10       Impact factor: 44.544

9.  Cyclin D1 (Bcl-1, PRAD1) protein expression in low-grade B-cell lymphomas and reactive hyperplasia.

Authors:  W I Yang; L R Zukerberg; T Motokura; A Arnold; N L Harris
Journal:  Am J Pathol       Date:  1994-07       Impact factor: 4.307

10.  Primary mediastinal lymphoma in adults.

Authors:  A K Lichtenstein; A Levine; C R Taylor; W Boswell; S Rossman; D I Feinstein; R J Lukes
Journal:  Am J Med       Date:  1980-04       Impact factor: 4.965

View more
  3 in total

Review 1.  Transformed diffuse large B-cell lymphoma from marginal zone lymphoma in the anterior mediastinum: A case report and review of the literature.

Authors:  Wataru Kitamura; Noboru Asada; Tetsuya Tabata; Rei Shibata; Tatsuya Nishi; Yuka Kato; Hiroki Takasuka; Hideaki Fujiwara; Daisuke Ennishi; Hisakazu Nishimori; Nobuharu Fujii; Ken-Ichi Matsuoka; Katsuyuki Kiura; Tadashi Yoshino; Yoshinobu Maeda
Journal:  J Clin Exp Hematop       Date:  2021-11-26

2.  A systematic review and meta-analysis of thymic mucosa-associated lymphoid tissue lymphoma.

Authors:  Meng-Xin Zhou; Ye-Ye Chen; Jia-Qi Zhang; Wen-Liang Bai; Cheng Huang; Chao Guo; Hong-Sheng Liu; Shan-Qing Li
Journal:  J Thorac Dis       Date:  2022-08       Impact factor: 3.005

3.  Splenic B-Cell Lymphomas with Diffuse Cyclin D1 Protein Expression and Increased Prolymphocytic Cells: A Previously Unrecognized Diagnostic Pitfall.

Authors:  Khaled Algashaamy; Yaohong Tan; Nicolas Mackrides; Alvaro Alencar; Jing-Hong Peng; Joseph Rosenblatt; Juan P Alderuccio; Izidore S Lossos; Francisco Vega; Jennifer Chapman
Journal:  Case Rep Hematol       Date:  2018-09-27
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.